Optimal radiotherapy for non-small-cell lung cancer: Current progress and future challenges

General Thoracic and Cardiovascular Surgery

Volumn 60, Issue 3, 2012, Pages 127-131

  Ishikura, Satoshi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Intensity modulated radiation therapy; Non small cell lung cancer; Particle therapy; Radiotherapy; Stereotactic body radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG SURGERY; LYMPH NODE IRRADIATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTICLE RADIATION; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; PROTON THERAPY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; STEREOTACTIC BODY RADIATION THERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROTONS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84860702659     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-011-0832-y     Document Type: Review

References (41)

1. Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1079-85. (Pubitemid 27230032)
2. Armstrong J, McGibney C. The impact of three-dimensional radiation on the treatment of non-small cell lung cancer. Radiother Oncol 2000;56:157-67. (Pubitemid 30601672)
3. Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Galmarini DH, Garton GR, et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 1996;6:98-104. (Pubitemid 26119516)
4. Gauden S, Ramsay J, Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995;108:1278-82.
5. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517-23. (Pubitemid 23331116)
6. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
7. Morita K, Fuwa N, Suzuki Y, Nishio M, Sakai K, Tamaki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 1997;42:31-6. (Pubitemid 27078109)
8. Willers H, Wurschmidt F, Bunemann H, Heilmann HP. Highdose radiation therapy alone for inoperable non-small cell lung cancer: experience with prolonged overall treatment times. Acta Oncol 1998;37:101-5. (Pubitemid 28179808)
9. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for nonsmall cell lung cancer: a meta-analysis. Radiother Oncol 2010; 95:32-40.
10. Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107-14. (Pubitemid 40381006)
11. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: fouryear results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-82.
12. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-31. (Pubitemid 41628038)
13. Timmerman R. RTOG 0236: stereotactic body radiation therapy (SBRT) to treat medically inoperable early stage lung cancer patients. Int J Radiat Oncol Biol Phys 2009;75(suppl):S3.
14. Onishi H, Araki T , Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-31. (Pubitemid 39318910)
15. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, et al. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 2010;78(suppl):S27-8.
16. Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008;3: 46-52.
17. Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. Eur J Cardiothorac Surg 2005; 28:380-3. (Pubitemid 41169187)
18. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring D, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA nonsmall cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009;4:1.
19. Perez C. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung: preliminary report by the Radiation Therapy Oncology Group. Cancer 1980;45:2744-53. (Pubitemid 10063330)
20. LeChevalier T. Radioth erapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;83:417-23.
21. ICRU. Prescribing, recording, reporting, photon beam therapy. Bethesda: ICRU; 1993. Report No. 50.
22. ICRU. Prescribing, recording, reporting, photon beam therapy. Supplement to ICRU Report 50. Bethesda: ICRU: 1999. Report No. 62.
23. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000;48: 1015-24.
24. ICRU. Prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT) (ICRU Report 83). J ICRU 2010;10(1).
25. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 2009;4:5.
26. Belderbos JS, Kepka L, Spring Kong FM, Martel MK, Videtic GM, Jeremic B. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2008;72:335-42.
27. Grills IS, Yan D, Martinez AA, Vicini FA, Wong JW, Kestin LL. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003;57:875-90. (Pubitemid 37194316)
28. Senan S, Burgers S, Samson MJ, van Klaveren RJ, Oei SS, van Sornsen de Koste J, et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:999-1006. (Pubitemid 35299439)
29. Rosenzweig KE, Sim SE, Mychalczak B, Braban LE, Schindelheim R, Leibel SA. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:681-5. (Pubitemid 32519597)
30. Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 2007;30:239-44. (Pubitemid 46884142)
31. Kepka L, Bujko K, Zolciak-Siwinska A. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques: a retrospective analysis. Acta Oncol 2008;47:95-103.
32. Bradley J. Phase I results of R TOG 0117: a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable non-small cell lung cancer. J Clin Oncol 2005;24:7063A.
33. Schild S. Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small cell lung cancer. Int J Rad Oncol Biol Phys 2005;63: S44.
34. Rosenman JG, Halle JS, Socinski MA, Deschesne K, Moore DT, Johnson H, et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys 2002;54:348-56. (Pubitemid 35286797)
35. Blackstock A, Socinski MA, Bogart J, Gu L, Wang X, Green M, et al. Induction plus concurrent chemotherapy with high dose (74 Gy) 3 dimensional (3-D) thoracic radiotherapy in stage III non-small cell lung cancer. Preliminary report of CALGB 30105. J Clin Oncol 2006;24:7042.
36. Schild SE, Bogart JA. Innovation s in the radiotherapy of nonsmall cell lung cancer. J Thorac Oncol 2006;1:85-92. (Pubitemid 47164028)
37. Chang JY, Zhang X, Wang X, Kang Y , Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:1087-96.
38. Pijls-Johannesma M, Grutters JP, Lambin P, Ruysscher DD. Particle therapy in lung cancer: where do we stand? Cancer Treat Rev 2008;34:259-67.
39. Soares HP, Kumar A, Daniels S, Swann S, Cantor A, Hozo I, et al. Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA 2005;293: 970-8. (Pubitemid 40271129)
40. Komaki R, Seiferheld W, Curran W, Langer C, Lee JS, Hauser S, et al. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): analysis of failures in a phase III study (RTOG 9410). Int J Radiat Oncol Biol Phys 2000;48(suppl): S113.
41. Choy H, Jain AK, Moughan J, Curran W , Whipple G, Demas WF, et al. RTOG 0017: a phase I trial of concurrent gemcitabine/ carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer. J Thorac Oncol 2009; 4:80-6.